Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 126, Issue 6, Pages 1105-1118Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2010.10.008
Keywords
-
Categories
Funding
- National Institutes of Health
- GlaxoSmithKline
- Food Allergy and Anaphylaxis Network, Gerber, Mead Johnson
- Dyax Corp
- Food Allergy and Anaphylaxis Network, Mead Johnson
- National Peanut Board
- Food Allergy Initiative
- National Institutes of Health (Division of Receipt and Referral, National Institute of Allergy and Infectious Diseases, National Center for Complementary and Alternative Medicine)
- Phadia AB
- Genentech
- National Institutes of Health (National Institute of Allergy and Infectious Diseases)
- National Institute of Health Research, UK
- American Academy of Allergy, Asthma, and Immunology
- National Eczema Association
- US Department of Agriculture
- Canned Food Alliance
- New Jersey Department of Health and Senior Services
- Dey
- Novartis
- Astellas
- Ferndale
- Johnson Johnson
- Sinclair
- Stiefel
- Therapeutics Inc.
- American Gastrointestinal Association
- ALZA
- Astellas Pharma US, Inc
- Asubio Pharmaceuticals, Inc
- Centocor, Inc
- Corgentech
- Nucryst Pharmaceuticals
- Seattle Genetics
- Shionogi USA
- Merck
- Sepracor
- Dey Laboratories
- Schering-Plough
- AstraZenica
- TEVA
- Pfizer
- MEDA
- Alcon
- Intelliject
- US Food and Drug Administration
- AllerGen
- Canadian Allergy
- Asthma and Immunology Foundation/Anaphylaxis Canada
- Canadian Institutes of Health Research
- AstraZeneca Foundation
- Aventis
- Child Health Center Board
- CNMC Research Advisory Council
- National Association of Chain Drug Stores Foundation
- National Institutes of Health (National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute)
- Novartis/Genentech
- Robert Woods Johnson Foundation
- US Centers for Disease Control and Prevention
- US Public Health Service
- Washington, DC, Department of Health